Common Stock SEC Reporting - Delinquent
OTC Pink Limited Information
Contact Info
  • 3200 Beechleaf Court
  • Suite 900
  • Raleigh, NC 27709

  • Phone: (609) 986-1780
Business Description

Not Available

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Not Available
Latest Report Dec 31, 2015 10-K
CIK 0001338095
Fiscal Year End 12/31
OTC Marketplace OTC Pink Limited
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Not Available
Company Directors
Not Available
Company Notes
  • Note = On April 30, 2016, NephroGenex, Inc. filed a voluntary petition for relief under Chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware.
Service Providers
Accounting/Auditing Firm
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available
NRXGQ Security Details
Share Structure
Market Value1 Not Available
Authorized Shares Not Available
Outstanding Shares Not Available
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Transfer Agent(s)
Shareholders of Record Not Available
Short Selling Data
Short Interest 311 (0%)
Sep 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security